 |
Insilicos is developing new biomarkers with the potential to revolutionize medicine, by providing better diagnoses of disease, and by enabling development of new therapies.
We are applying pattern-recognition techniques to proteomics. Pattern-recognition is a mathematical technique to identify patterns in complex data. Proteomics is the study of the different proteins in our bodies, how they break, and how they can be repaired.
Our initial focus is diagnostics and drug research related to cardiovascular disease.
| |
|
Insilicos Appoints Fraley to Senior Scientist Post
Insilicos has appointed Dr. Chris Fraley as Senior Scientist for the company. A specialist in statistical computing and data mining, Dr. Fraley will lead a project to develop predictive models of disease based on advanced statistical techniques.
Details: News
Insilicos Awarded Grant to Study Ensemble Learning
The National Institutes of Health has awarded Insilicos $900,000 to apply a statistical approach called Ensemble Learning to biomedical research.
Details: News
Insilicos Awarded Grant for Life Science Computing
The National Institutes of Health has awarded Insilicos a grant to improve medical research data management software.
Details: News
Insilicos Wins NIH Grant for Manufacturing
Insilicos has been awarded an NIH Manufacturing Assistance Program (MAP) grant to develop procedures for handling diagnostic blood samples.
Details: News
Insilicos Heart Disease Project Wins Research Funding
Washington Technology Center has awarded Research and Technology Development funding based on a proposal from Insilicos in collaboration with the University of Washington.
Details: News
|
|
|
|
